Page last updated: 2024-08-17

carbon tetrachloride and sphingosine

carbon tetrachloride has been researched along with sphingosine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chun, J; Fujita, R; Iitsuka, S; Ikeda, H; Inoue, Y; Ishii, I; Kume, Y; Nishikawa, T; Ohtomo, N; Omata, M; Shimosawa, T; Tanoue, Y; Tomiya, T; Watanabe, N; Yatomi, Y1
Ikeda, H; Inoue, Y; Koike, K; Kume, Y; Nakagawa, H; Nakamura, K; Nishikawa, T; Ohkawa, R; Ohtomo, N; Okubo, S; Tanoue, Y; Tomiya, T; Watanabe, N; Yatomi, Y; Yokota, H; Yoshida, H1
Kong, Y; Tang, N; Wang, H; Wang, S1
Álvarez, M; Crespo, I; González-Fernández, B; González-Gallego, J; San-Miguel, B; Sánchez, DI; Tuñón, MJ1

Other Studies

4 other study(ies) available for carbon tetrachloride and sphingosine

ArticleYear
Sphingosine 1-phosphate regulates regeneration and fibrosis after liver injury via sphingosine 1-phosphate receptor 2.
    Journal of lipid research, 2009, Volume: 50, Issue:3

    Topics: Animals; Carbon Tetrachloride; Dimethylnitrosamine; Female; Hepatocytes; Liver; Liver Cirrhosis; Liver Regeneration; Lysophospholipids; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Proliferating Cell Nuclear Antigen; Receptors, Lysosphingolipid; Sphingosine; Sphingosine-1-Phosphate Receptors

2009
Plasma concentration of bioactive lipid mediator sphingosine 1-phosphate is reduced in patients with chronic hepatitis C.
    Clinica chimica acta; international journal of clinical chemistry, 2010, May-02, Volume: 411, Issue:9-10

    Topics: Aged; Aged, 80 and over; Animals; Blood Proteins; Carbon Tetrachloride; Female; Hemoglobins; Hepatitis C, Chronic; Humans; Hyaluronic Acid; Liver; Liver Cirrhosis; Lysophospholipids; Male; Middle Aged; Platelet Count; Rats; Rats, Sprague-Dawley; Serum Albumin; Sex Characteristics; Sphingosine

2010
FTY720, a sphingosine-1 phosphate receptor modulator, improves liver fibrosis in a mouse model by impairing the motility of bone marrow-derived mesenchymal stem cells.
    Inflammation, 2014, Volume: 37, Issue:4

    Topics: Animals; Bone Marrow Cells; Carbon Tetrachloride; Cell Movement; Disease Models, Animal; Fibrosis; Fingolimod Hydrochloride; Immunosuppressive Agents; Liver Cirrhosis; Mesenchymal Stem Cells; Mice; Mice, Inbred ICR; Mice, SCID; Propylene Glycols; Receptors, Lysosphingolipid; Signal Transduction; Sphingosine; Wound Healing

2014
Inhibition of the SphK1/S1P signaling pathway by melatonin in mice with liver fibrosis and human hepatic stellate cells.
    BioFactors (Oxford, England), 2017, Volume: 43, Issue:2

    Topics: Animals; Carbon Tetrachloride; Cell Line; Gene Expression Regulation; Hepatic Stellate Cells; Humans; Indoles; Lipid Metabolism; Liver Cirrhosis; Lysophospholipids; Male; Melatonin; Mice; Phosphotransferases (Alcohol Group Acceptor); Receptors, Lysosphingolipid; Signal Transduction; Sphingosine; Sphingosine-1-Phosphate Receptors

2017